HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a vaccine shield transplant patients from HPV?
⭐️ VACCINE ⭐️ OngoingThis study looks at whether the Gardasil 9 vaccine can help prevent HPV infection in people who have had a stem cell transplant for blood cancer. About 48 adults will receive the vaccine as part of their usual post-transplant care. Researchers will measure antibody levels to see …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 02:26 UTC
-
New vaccine aims to shield transplant patients from deadly virus
⭐️ VACCINE ⭐️ OngoingThis study tests a vaccine called Triplex to prevent cytomegalovirus (CMV) infection in adults who have received a stem cell transplant. CMV can cause serious illness in people with weakened immune systems. The vaccine uses harmless pieces of CMV DNA to help the body build immuni…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:05 UTC
-
Targeted drug shows promise for rare cancers with ALK mutation
Disease control OngoingThis study tested the drug crizotinib in people with advanced cancers that have a specific genetic change called ALK rearrangement. The goal was to see if the drug could shrink or stop the growth of these tumors. Only 5 patients took part, and the study is no longer enrolling new…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:43 UTC
-
Targeted drug shows promise for rare EGFR-Mutant cancers
Disease control OngoingThis study tests a drug called osimertinib in people with advanced cancers that have specific EGFR gene mutations. The drug blocks a faulty protein that helps cancer grow. Researchers want to see if it can shrink tumors or slow the disease. The trial includes 19 adults with vario…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
Targeted drug shows promise for rare BRAF-driven cancers
Disease control OngoingThis study tested the drug trametinib in 35 adults with advanced cancers that have specific BRAF gene mutations or fusions. The goal was to see if trametinib could shrink tumors or stop them from growing by blocking certain proteins. The trial is no longer recruiting, and results…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
Targeted therapy shows promise for rare HER2-Positive cancers
Disease control OngoingThis study tests a drug called ado-trastuzumab emtansine in people with advanced cancers that have too many HER2 receptors (HER2 amplification), except breast and stomach cancers. The drug combines an antibody that targets HER2 with a chemotherapy agent to kill cancer cells. Rese…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
Radiation after immunotherapy: a new hope for cancer control?
Disease control OngoingThis study looks at whether giving radiation therapy to cancer patients whose disease has spread or grown after immunotherapy can help control the cancer. About 230 adults with metastatic or blood cancers will receive radiation to see if it stops or shrinks tumors. The goal is to…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:39 UTC
-
Can genetically engineered goat milk stop a deadly transplant side effect?
Disease control TerminatedThis early-stage trial tests whether drinking milk from goats genetically modified to produce a human enzyme (lysozyme) can help prevent graft-versus-host disease (GVHD) in people with blood cancer receiving a donor stem cell transplant. About 53 participants will drink a daily a…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 02:39 UTC
-
New drug aimed at taming Immunotherapy's worst side effects
Disease control TerminatedThis study was designed to test if itacitinib can help cancer patients whose immune system overreacts to immunotherapy drugs, causing side effects that steroids can't control. The drug works by calming the immune response. However, the trial was withdrawn before enrolling any par…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: Douglas Johnson • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
Targeted drug shows promise for rare genetic cancers
Disease control OngoingThis study tests a drug called trametinib in 50 patients whose cancers have a specific genetic change called an NF1 mutation. The drug blocks certain proteins that help cancer cells grow. The goal is to see if the drug can shrink tumors or stop them from growing.
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:25 UTC
-
Donor cells take on stubborn virus in transplant patients
Disease control OngoingThis study tests whether specially trained white blood cells from donors can treat a stubborn CMV infection in people who have had a stem cell transplant. About 49 participants will receive these cells to see if the infection clears. The goal is to control the virus when standard…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:25 UTC
-
Gut bacteria booster may ease transplant side effects
Disease control OngoingThis early-phase study tests a probiotic called CBM588 in 36 people who have had a donor stem cell transplant for blood cancers. The goal is to see if it is safe and can improve gut bacteria diversity, which may help prevent severe diarrhea and other gut problems. Participants ta…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 02:25 UTC
-
Targeted drug shows promise for HER2-Mutated cancers
Disease control OngoingThis study tests a drug called afatinib in 40 patients whose advanced cancers have a specific genetic change called a HER2 mutation. Afatinib works by blocking the HER2 protein, which may help stop cancer cells from growing. The goal is to see if the drug can shrink tumors or slo…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:24 UTC
-
New drug targets AKT mutations in Hard-to-Treat cancers
Disease control OngoingThis study tested a drug called AZD5363 in 35 people with advanced cancers that have a specific genetic change (AKT mutation). The drug works by blocking a protein that helps cancer cells grow. The goal was to see if the drug could shrink tumors or stop them from growing. This is…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New drug shows promise for stem cell transplant complication
Disease control OngoingThis study tests whether acalabrutinib can help people with chronic graft-versus-host disease (GVHD), a condition where donor immune cells attack the recipient's body after a stem cell transplant. About 51 adults with moderate-to-severe GVHD that did not improve with steroids wil…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo therapy aims to boost immune attack on hard-to-treat cancers
Disease control OngoingThis early-phase study tests the safety of adding the drug atezolizumab after a patient's own immune cells have been collected, multiplied, and infused back to fight cancer. It includes 40 adults with advanced blood or solid tumors that no longer respond to standard treatments. T…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Targeted drug shows promise for BRCA-Linked tumors
Disease control OngoingThis study tests a drug called AZD1775 in people with advanced cancers that have a BRCA gene mutation. The drug blocks a protein that cancer cells need to grow. Researchers want to see if it can shrink tumors or stop them from getting worse. About 35 adults with various solid tum…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Targeted drug duo takes on rare BRAF cancers in new trial
Disease control OngoingThis study tests two targeted drugs, dabrafenib and trametinib, in 35 adults with advanced cancers (like lymphoma or solid tumors) that have a BRAF V600 mutation. The drugs block proteins that help cancer grow. The goal is to see if the combination can shrink tumors or stop them …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Targeted drug shows promise for rare genetic cancers
Disease control OngoingThis study is for people with advanced cancers that have a specific genetic change called an NF2 mutation. The drug defactinib blocks a protein that may help these cancers grow. Researchers want to see if it can shrink tumors or stop them from getting worse. About 35 adults are t…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for Hard-to-Treat cancers: targeted pill shows promise
Disease control OngoingThis study tests a drug called palbociclib in people with advanced cancers that have specific genetic changes (CCND1, 2, or 3 amplification). The drug blocks certain proteins that help cancer grow. Researchers want to see if it can shrink tumors or stop them from growing. About 4…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Targeted drug shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called taselisib in 70 people with advanced cancers (except breast cancer) that have a specific genetic change called PIK3CA mutation. The drug works by blocking a protein that helps cancer cells grow. Researchers want to see if the drug can shrink tumors …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Childhood cancer immunotherapy trial pulled before starting
Disease control TerminatedThis study was designed to test two immunotherapy drugs, nivolumab and ipilimumab, in children and young adults with cancers that returned or didn't respond to treatment and have many genetic mutations. The goal was to see if the combination could shrink tumors or help patients l…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug targets cancers missing PTEN gene in early trial
Disease control OngoingThis study tests a drug called GSK2636771 in people whose cancers have lost a gene called PTEN. The drug blocks a protein (PI3K-beta) that helps these cancer cells grow. Researchers want to see if the drug can shrink tumors or stop them from growing. About 35 adults with advanced…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Targeted drug shows promise for rare Mutation-Driven cancers
Disease control OngoingThis study tested the drug trametinib in 4 people with advanced cancers that have GNAQ or GNA11 mutations. Trametinib blocks certain proteins that help these cancer cells grow. The goal was to see if the drug could shrink tumors or stop them from growing.
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New antibody takes aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-stage study tests a new antibody drug called Hu8F4 in 72 people with advanced blood cancers like leukemia and myelodysplastic syndrome. The main goals are to find the safest dose and check for side effects. The drug works by targeting a protein on cancer cells to stop …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New transplant timing strategy may tame High-Risk blood cancers
Disease control OngoingThis study tests a specific schedule of chemotherapy drugs (busulfan and fludarabine) followed by a donor stem cell transplant for people with high-risk blood cancers like leukemia and lymphoma. After the transplant, a drug called cyclophosphamide is given to help prevent the don…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
New drug targets genetic weakness in Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called binimetinib in 53 adults with advanced cancers (like lymphoma or solid tumors) that have a specific genetic change called an NRAS mutation. The drug blocks proteins that help cancer grow. The main goal is to see if the drug can shrink tumors or stop…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
New drug targets genetic weakness in Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called GSK2636771 in 24 adults with advanced cancers that have a specific genetic change (PTEN mutation or deletion). The drug blocks a protein that may help these cancer cells grow. The goal is to see if the drug can shrink tumors or stop them from growin…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Targeted drug trial aims to block cancer growth in patients with specific genetic change
Disease control OngoingThis study is testing whether the drug crizotinib can shrink or stop the growth of advanced cancers that have a specific genetic change called a ROS1 translocation. The trial includes patients with various advanced solid tumors, lymphoma, or multiple myeloma that have not respond…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 20, 2026 16:04 UTC
-
Could a home device catch heart trouble early in childhood cancer survivors?
Diagnosis OngoingThis study checks if portable, easy-to-use devices can detect early signs of heart damage in childhood cancer survivors. About 149 people who finished cancer treatment will use these devices at home and in the clinic. The goal is to see if these tools are as accurate as standard …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Apr 26, 2026 19:39 UTC
-
Donor vaccine may shield transplant patients from dangerous virus
Prevention OngoingThis early-phase trial tests whether vaccinating stem cell donors against cytomegalovirus (CMV) can help protect the transplant recipient from CMV infection. About 34 people with blood cancers receiving a donor stem cell transplant will have their donors vaccinated before donatio…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated May 06, 2026 16:13 UTC
-
Exercise may ease chemo nerve pain in new trial
Symptom relief OngoingThis study looks at whether exercise can reduce symptoms of chemotherapy-induced peripheral neuropathy (CIPN), such as pain, numbness, and tingling in the hands and feet. About 133 cancer patients who have nerve damage from chemo will either do an exercise program or receive usua…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated May 17, 2026 02:43 UTC
-
Speed of opioid infusion may affect pain relief and addiction risk in cancer patients
Symptom relief OngoingThis study looks at how fast or slow a painkiller (hydromorphone) is given through an IV affects cancer patients' pain relief and their risk of misusing the drug. About 84 hospitalized cancer patients with moderate to severe pain will receive the same medicine at two different sp…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 02:42 UTC
-
Could a simple pill boost Radiation's power against brain cancer?
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) combined with whole-brain radiation in people whose cancer has spread to the brain. The goal is to find the safest dose and see if the drug makes radiation work better by sensitizing tumor cells. Only 11 parti…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 17, 2026 02:40 UTC
-
Can a short therapy session beat cancer insomnia? new trial aims to find out
Symptom relief OngoingThis study tests whether a brief behavioral therapy program (BBT-CI) works better than healthy eating education (HEAL) for reducing insomnia in cancer patients. About 400 adults with stage I-IV cancer who are currently receiving treatment and have sleep problems will take part. T…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Can a nutraceutical soothe chemo nerve damage?
Symptom relief OngoingThis study tests whether a natural supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. About 88 adults who have had these symptoms for at least 3 months will take PEA or a placebo for 8 weeks. The goal is to see if PEA i…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Can a common mental health drug help cancer patients eat better?
Symptom relief OngoingThis study compares two drugs, olanzapine and megestrol acetate, to see which works better for improving appetite and preventing weight loss in people with advanced cancer. About 227 patients will take one of the two medications for four weeks. The goal is to find a more effectiv…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Can opioids help cancer patients breathe easier during exercise?
Symptom relief OngoingThis study tests whether fast-acting opioids (fentanyl or morphine) can reduce shortness of breath during physical activity in cancer patients who already take strong painkillers. About 150 adults with active cancer and moderate-to-severe exertional dyspnea will take the drug or …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 12, 2026 13:39 UTC
-
Money stress in cancer care: new study tests financial coaching
Symptom relief OngoingThis study tests whether a financial navigation program can reduce money-related stress for cancer patients and their caregivers. About 331 adults with advanced cancer or blood cancers will receive either financial coaching or usual care. The goal is to see if this help lowers fi…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC
-
New combo therapy aims to beat Cancer-Related insomnia
Symptom relief OngoingThis study tests whether combining cognitive behavioral therapy with a stimulant, melatonin, and light therapy can improve sleep in cancer patients. About 68 adults currently on cancer treatment who have poor sleep will participate. The goal is to reduce sleep problems, fatigue, …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
New study aims to get cancer survivors moving
Symptom relief OngoingThis study tests whether personalized coaching and mobile apps can help young adult cancer survivors become more physically active and improve their diet. About 374 participants will try different behavioral programs designed to fit their needs. The goal is to see if these progra…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC
-
Marijuana vs. opioids: cancer patients weigh in on pain relief
Symptom relief OngoingThis study looks at how cancer patients view using marijuana products (THC or CBD) along with opioids for pain relief. Researchers will survey 200 patients in Texas and Arizona to understand their preferences and symptom control. The goal is to learn if adding marijuana helps pat…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:51 UTC
-
Racial disparities in immunotherapy: a new study seeks answers
Knowledge-focused OngoingThis study looks at whether African American and White cancer patients respond differently to a type of immunotherapy called checkpoint inhibitors. Researchers will collect blood, saliva, and health information from 2,100 patients to compare side effects and treatment success. Th…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: University of Rochester NCORP Research Base • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC
-
New PET tracer could reveal hidden cancers
Knowledge-focused OngoingThis early-phase study tests a new imaging agent called 68Ga-FAPI-46, which targets cells around tumors. About 26 adults with various cancers will receive the tracer and then have a PET/CT scan. The goal is to see where the tracer goes in the body and compare it to standard imagi…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC
-
What do parents really think about opioids for kids with cancer?
Knowledge-focused OngoingThis study surveys 110 parents of children with cancer to learn about their attitudes and beliefs regarding the risks of using opioids for pain. Many parents worry about giving these strong painkillers to their kids, sometimes even skipping doses or stopping early. The goal is to…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:39 UTC
-
Home hospital for cancer patients? study scrapped before it started
Knowledge-focused TerminatedThis study aimed to understand how often cancer patients with neutropenic fever (a fever with low white blood cells) have serious complications, to see if some could be safely treated at home instead of in the hospital. It planned to review records of low-risk patients treated at…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:39 UTC
-
How do patients and doctors feel about telemedicine for cancer care?
Knowledge-focused OngoingThis study surveys 200 patients and healthcare providers to understand their opinions on using telemedicine (video visits) for radiation oncology. Participants must be 18 or older, English-speaking, and have had at least one telemedicine visit. The goal is to measure satisfaction…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:26 UTC
-
Pandemic's toll on cancer patients with nerve pain under microscope
Knowledge-focused OngoingThis study looks at how the COVID-19 pandemic impacted the well-being of cancer patients who also have nerve pain (neuropathy). Researchers want to learn about their quality of life and whether a therapy called neurofeedback made any difference. The study involves 274 people who …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:25 UTC
-
Can a smartphone app get young cancer survivors moving? new study aims to find out.
Knowledge-focused OngoingThis study looks at whether a special program using a mobile app and social media can help teens and young adults who survived childhood cancer become more physically active. About 387 survivors will either use the full program or just a fitness tracker alone. The goal is to see …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 17, 2026 02:25 UTC
-
Team approach aims to help seniors bounce back after stem cell transplant
Knowledge-focused OngoingThis study looks at whether a team of healthcare professionals can help older adults (65 and older) stay healthy and recover better after a stem cell transplant for blood cancer. About 40 participants will see multiple providers to improve their fitness before and after the trans…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:24 UTC
-
Transplant Survivors' hidden heart risk under the microscope
Knowledge-focused OngoingThis study follows 350 stem cell transplant survivors to see how their heart, lungs, and muscles work together over two years. Researchers measure exercise capacity and other health markers to learn why transplant survivors have a higher risk of heart disease. Participants includ…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:24 UTC
-
Cancer Patients' pandemic struggles revealed in new study
Knowledge-focused OngoingThis study looked at how the COVID-19 pandemic impacted the well-being and quality of life of over 13,000 cancer patients and survivors. Researchers used questionnaires to gather information on experiences like exposure to the virus, isolation, and financial disruptions. The goal…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New study aims to spot malnutrition in older cancer patients
Knowledge-focused OngoingThis study looks at how well nutritional check-ups can find malnutrition in older adults with cancer. About 180 participants will undergo special assessments to see if their nutrition affects their health and survival. The goal is to help doctors better identify and address malnu…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Brain waves reveal if unresponsive patients hear loved ones in final days
Knowledge-focused TerminatedThis study uses a brain wave test (EEG) to check if cancer patients who appear unresponsive in their last days can still hear or feel. Researchers will measure brain activity before and after speaking to them. The goal is to help families and doctors understand what patients may …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Virtual team meetings aim to boost doctor engagement
Knowledge-focused OngoingThis study looks at whether a special online meeting program (called ECHO) can help imaging doctors feel more connected and work more efficiently. About 36 doctors from MD Anderson will take part. The goal is to see if these virtual meetings improve teamwork and job satisfaction.
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Testosterone levels linked to brain health? new study investigates
Knowledge-focused OngoingThis study looks at whether having naturally low testosterone levels increases the risk of dementia, depression, or anxiety. Researchers will analyze genetic data from large biobanks (like UK Biobank) to see if certain genes linked to low testosterone are also linked to these men…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Teens with cancer help Fine-Tune symptom survey
Knowledge-focused OngoingThis study tests a symptom questionnaire designed for teenagers with cancer. Researchers interview teens aged 13-17 to see if the survey is easy to use and accurately captures their symptoms. The goal is to improve the tool so doctors can better understand and manage what teens g…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
New app aims to simplify radiation treatment for cancer patients
Knowledge-focused OngoingThis study tests a mobile app called Oncpatient designed to help cancer patients manage their radiation therapy. Radiation treatment can be confusing, with complex schedules and side effects. The app provides easy-to-access information and guidance. Researchers want to see if pat…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC
-
Exercise and supplement combo tested in childhood cancer survivors at risk for diabetes
Knowledge-focused OngoingThis study looks at whether a program of exercise and a dietary supplement called nicotinamide riboside (similar to vitamin B3) can improve muscle health and insulin resistance in adults who survived childhood cancer and now have prediabetes. About 20 participants will take part …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
Breaking barriers: new study aims to get more minority cancer patients into clinical trials
Knowledge-focused OngoingThis study aims to understand why minority cancer patients often do not take part in clinical trials. Researchers will survey 590 patients to learn about their challenges and preferences. The information will be used to create a personalized educational platform to help these pat…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC
-
New study aims to uncover the hidden costs of cancer
Knowledge-focused OngoingThis study looks at the financial challenges people face after a cancer diagnosis. Researchers are surveying 625 English- or Spanish-speaking adults diagnosed within the past year to understand what factors contribute to financial stress. The goal is to identify targets for futur…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC
-
New dosing method for Kids' cancer drug aims to reduce side effects in infants
Knowledge-focused OngoingThis study compares a new dosing method for the cancer drug vincristine in infants and young children to the standard method used in older children. The goal is to see if the new approach gives similar drug levels in the blood with fewer side effects. About 83 children up to 12 y…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC
-
Masks vs screens: which makes patients feel more cared for?
Knowledge-focused OngoingThis study looks at how cancer patients perceive their doctor's empathy during the COVID-19 pandemic. It compares in-person visits where doctors wear protective gear (like masks) to video calls where doctors do not wear masks. The goal is to see which way of communicating makes p…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC